Journal Article Summary
The article investigates the effectiveness and safety of a topical finasteride spray solution for treating male androgenetic alopecia (AGA), commonly known as male pattern baldness. AGA is a prevalent condition that affects a significant number of men, often leading to a decline in quality of life. While oral finasteride has been a standard treatment, some patients experience undesirable side effects, prompting the need for alternative delivery methods that could minimize systemic exposure and associated risks.
In this phase III clinical trial, 458 adult male participants with AGA were randomly assigned to receive either the topical finasteride spray, a placebo, or oral finasteride over a 24-week period. The primary measure of success was the change in hair count in a targeted area of the scalp. Results showed that those using the topical finasteride experienced a significantly greater increase in hair count compared to the placebo group, with a mean change of 20.2 hairs versus 6.7 hairs. Additionally, the topical treatment demonstrated a lower impact on serum dihydrotestosterone (DHT) levels, which is associated with fewer sexual side effects compared to oral finasteride.
Despite these promising findings, the study has limitations, including a relatively short duration and a focus on a specific population, which may not represent all men with AGA. Patients should be aware that while topical finasteride appears to be effective and well-tolerated, individual responses can vary. It is essential for readers to consult with healthcare professionals to discuss potential benefits and risks, especially if they have concerns about hair loss treatments or experience any side effects.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Piraccini B.M., Blume‐Peytavi U., Scarci F., Jansat J.M., Falqués M., Otero R., Tamarit M.L., Galván J., et al.. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. Journal of the European Academy of Dermatology and Venereology 2021. DOI: 10.1111/jdv.17738. PMID: 34634163. PMCID: PMC9297965.
Featured Pill Pals Product
Finasteride 1 mg Tablets --- Ascend Labs --- Generic for Propecia --- Ascend
Finasteride 1 mg Tablets — Ascend Labs — Generic for Propecia — Ascend is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
